Histone deacetylases reduction causes defect of Nrf2 response, leading to a reduction of anti-oxidant capacity in COPD

N. Mercado, C. Thomas, K. Chana, L. Donnelly, P. J. Barnes, K. Ito (London, United Kingdom)

Source: Annual Congress 2010 - Pathology and immunology of COPD
Session: Pathology and immunology of COPD
Session type: Oral Presentation
Number: 5350
Disease area: Airway diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
N. Mercado, C. Thomas, K. Chana, L. Donnelly, P. J. Barnes, K. Ito (London, United Kingdom). Histone deacetylases reduction causes defect of Nrf2 response, leading to a reduction of anti-oxidant capacity in COPD. Eur Respir J 2010; 36: Suppl. 54, 5350

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Decreased histone deacetylase activity in COPD
Source: Annual Congress 2008 - Epigenetic modifications in lung disease
Year: 2008


Oxidative stress alters histone acetylation and deacetylation: potential mechanism in inflammatory gene transcription
Source: Eur Respir J 2001; 18: Suppl. 33, 182s
Year: 2001

Oxidative stress-mediated decrease in histone deacetylase activity is attenuated by N-acetyl-L-cysteine but not by Iκ-B kinase inhibition in alveolar epithelial cells
Source: Eur Respir J 2004; 24: Suppl. 48, 29s
Year: 2004

Histone deacetylase activity is reduced in COPD. Modulation by theophylline
Source: Eur Respir J 2003; 22: Suppl. 45, 4s
Year: 2003

Steroids and histone deacetylase in ventilation-induced gene transcription
Source: Eur Respir J 2007; 30: 865-877
Year: 2007



Histone deacetylase activity and gene expression in COPD patients
Source: Eur Respir J 2001; 18: Suppl. 33, 316s
Year: 2001

Histone acetylation and deacetylation: importance in inflammatory lung diseases
Source: Eur Respir J 2005; 25: 552-563
Year: 2005



The role of histone deacetylase 9 in the imbalance of Th17/Treg in bronchial asthma
Source: Annual Congress 2012 - Mechanisms of asthma
Year: 2012


Histone deacetylases (HDACs) and lung disease
Source: Annual Congress 2011 - Why is epigenetics important for lung disease?
Year: 2011


Histone deacetylase inhibition promotes fibroblast apoptosis and ameliorates pulmonary fibrosis in mice
Source: Eur Respir J 2014; 43: 1448-1458
Year: 2014



DJ-1 and its anti-oxidative stress response regulates the expression of sirtuin-1 in COPD epithelial cells
Source: International Congress 2017 – Translational studies of lung disease
Year: 2017

Histone Deacetylase 7 regulates master transcription factors and modulates mitochondrial function
Source: International Congress 2017 – Experimental PH
Year: 2017

LSC Abstract – Histone deacetylase 7 mediated metabolic remodeling: A new crosslink between pulmonary hypertension and cancer
Source: International Congress 2016 – The nature of pulmonary hypertension
Year: 2016

Environmental particles (PM10) regulate IL-8 gene expression by oxidative stress-mediated histone acetylation
Source: Eur Respir J 2001; 18: Suppl. 33, 413s
Year: 2001

The role of histone deacetylase 2 (HDAC2) and glucocorticoid receptor (GR) isoforms α, β in patients with asthma–COPD overlap syndrome (ACOS)
Source: International Congress 2016 – Molecular targets in pulmonary disease
Year: 2016


Cigarette smoke increases histone acetylation in alveolar epithelial cells: a mechanism for enhanced gene expression
Source: Eur Respir J 2002; 20: Suppl. 38, 377s
Year: 2002

A role for histone acetylation/deacetylation in TNFα production from macrophages exposed to PM10
Source: Eur Respir J 2001; 18: Suppl. 33, 407s
Year: 2001

microRNA-223 suppresses histone deacetylase 2 in chronic obstructive pulmonary disease
Source: International Congress 2015 – Latest news on miRNAs in pulmonary research
Year: 2015


Histone deacetylase inhibition significantly augments human mesothelioma cellular response to chemotherapeutic agents
Source: Eur Respir J 2001; 18: Suppl. 33, 396s
Year: 2001